{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:05:01Z","timestamp":1785423901637,"version":"3.56.0"},"reference-count":33,"publisher":"Akademiai Kiado Zrt.","issue":"27","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,7,6]]},"abstract":"\n Bevezet\u00e9s:<\/jats:italic>\n A polycyst\u00e1s ovarium szindr\u00f3ma a reprodukt\u00edv kor\u00fa n\u0151k\n egyik leggyakoribb endokrin zavara, amely sz\u00e1mos metabolikus sz\u00f6v\u0151dm\u00e9nyt, k\u00fcls\u0151\n megjelen\u00e9st \u00e9rint\u0151 t\u00fcnetet \u00e9s pszichoszoci\u00e1lis kih\u00edv\u00e1st hozhat mag\u00e1val. Az\n \u00e9letmin\u0151s\u00e9get befoly\u00e1sol\u00f3 mechanizmusok pontos meg\u00e9rt\u00e9s\u00e9hez elengedhetetlen\n betegs\u00e9gspecifikus m\u00e9r\u0151eszk\u00f6z\u00f6k alkalmaz\u00e1sa, amelyek magyar nyelven\n korl\u00e1tozottan \u00e1llnak rendelkez\u00e9sre.\n C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n Kutat\u00e1sunk\n c\u00e9lja a Polycyst\u00e1s Ovarium Szindr\u00f3ma Specifikus \u00c9letmin\u0151s\u00e9g K\u00e9rd\u0151\u00edv magyar\n nyelv\u0171 v\u00e1ltozat\u00e1nak adapt\u00e1ci\u00f3ja \u00e9s pszichometriai jellemz\u0151inek le\u00edr\u00e1sa. Tov\u00e1bbi\n c\u00e9lkit\u0171z\u00e9s\u00fcnk a polycyst\u00e1s ovarium szindr\u00f3m\u00e1val diagnosztiz\u00e1lt \u00e9s az eg\u00e9szs\u00e9ges\n kontrollcsoport \u00e9letmin\u0151s\u00e9ge k\u00f6z\u00f6tti k\u00fcl\u00f6nbs\u00e9gek vizsg\u00e1lata. Emellett k\u00edv\u00e1ncsiak\n voltunk arra, hogy a testt\u00f6megindex, a negat\u00edv affektivit\u00e1s \u00e9s a testk\u00e9ppel\n kapcsolatos aggodalmak hogyan f\u00fcggenek \u00f6ssze a polycyst\u00e1s ovarium szindr\u00f3m\u00e1ra\n specifikus \u00e9letmin\u0151s\u00e9ggel.\n M\u00f3dszer:<\/jats:italic>\n Az online k\u00e9rd\u0151\u00edves\n adatfelv\u00e9tel 2024. \u00e1prilist\u00f3l okt\u00f3berig tartott (n = 854). Demogr\u00e1fiai v\u00e1ltoz\u00f3k\n mellett felv\u00e9telre ker\u00fclt a Polycyst\u00e1s Ovarium Szindr\u00f3ma Specifikus \u00c9letmin\u0151s\u00e9g\n K\u00e9rd\u0151\u00edv, az Eg\u00e9szs\u00e9g\u00fcgyi Vil\u00e1gszervezet R\u00f6vid\u00edtett \u00c9letmin\u0151s\u00e9g K\u00e9rd\u0151\u00edve, a\n Testk\u00e9ppel Kapcsolatos Aggodalmak K\u00e9rd\u0151\u00edv, illetve a Depresszi\u00f3, Szorong\u00e1s \u00e9s\n Stressz K\u00e9rd\u0151\u00edv.\n Eredm\u00e9nyek:<\/jats:italic>\n A konfirmat\u00edv faktoranal\u00edzis\n meger\u0151s\u00edtette az eredeti n\u00e9gyfaktoros strukt\u00fara megl\u00e9t\u00e9t. Az eg\u00e9szs\u00e9ges\n kontrollcsoport szignifik\u00e1nsan jobb \u00e9letmin\u0151s\u00e9gr\u0151l sz\u00e1molt be a fizikai \u00e9s\n pszichol\u00f3giai eg\u00e9szs\u00e9g, a k\u00f6rnyezet \u00e9s az \u00e1ltal\u00e1nos \u00e9letmin\u0151s\u00e9g alsk\u00e1l\u00e1kon, a\n szoci\u00e1lis kapcsolatok dimenzi\u00f3t vizsg\u00e1lva azonban nem mutatkozott elt\u00e9r\u00e9s a k\u00e9t\n csoport k\u00f6z\u00f6tt. Komplex medi\u00e1ci\u00f3s elemz\u00e9s\u00fcnk alapj\u00e1n elmondhat\u00f3, hogy a\n testt\u00f6megindex \u00e9s a negat\u00edv affektivit\u00e1s szignifik\u00e1ns, negat\u00edv hat\u00e1ssal van a\n polycyst\u00e1s ovarium szindr\u00f3m\u00e1ra specifikus \u00e9letmin\u0151s\u00e9gre, amely hat\u00e1s r\u00e9szben a\n testk\u00e9ppel kapcsolatos aggodalmak k\u00f6zvet\u00edt\u0151 mechanizmus\u00e1n kereszt\u00fcl \u00e9rv\u00e9nyes\u00fcl.\n Megbesz\u00e9l\u00e9s:<\/jats:italic>\n Vizsg\u00e1lati eredm\u00e9nyeink al\u00e1t\u00e1masztj\u00e1k a\n Polycyst\u00e1s Ovarium Szindr\u00f3ma Specifikus \u00c9letmin\u0151s\u00e9g K\u00e9rd\u0151\u00edv eredeti\n faktorstrukt\u00far\u00e1j\u00e1t. Az eg\u00e9szs\u00e9ges kontrollcsoporttal \u00f6sszehasonl\u00edtva a\n betegs\u00e9ggel \u00e9l\u0151 n\u0151k rosszabb \u00e9letmin\u0151s\u00e9gr\u0151l sz\u00e1moltak be t\u00f6bb dimenzi\u00f3 ment\u00e9n,\n ami \u00f6sszef\u00fcgg\u00e9sben \u00e1ll a nemzetk\u00f6zi szakirodalommal. Medi\u00e1ci\u00f3s elemz\u00e9seink\n r\u00e1vil\u00e1g\u00edtanak a metabolikus \u00e9s endokrin elt\u00e9r\u00e9sek, valamint a pszich\u00e9s t\u00e9nyez\u0151k\n k\u00f6z\u00f6tti komplex interakci\u00f3kra, hangs\u00falyozva a betegs\u00e9g multidiszciplin\u00e1ris\n megk\u00f6zel\u00edt\u00e9s\u00e9nek sz\u00fcks\u00e9gess\u00e9g\u00e9t.\n K\u00f6vetkeztet\u00e9s:<\/jats:italic>\n Eredm\u00e9nyeink\n alapj\u00e1n a Polycyst\u00e1s Ovarium Szindr\u00f3ma Specifikus \u00c9letmin\u0151s\u00e9g K\u00e9rd\u0151\u00edvet\n megb\u00edzhat\u00f3 \u00e9s valid m\u00e9r\u0151eszk\u00f6znek tartjuk. Orv Hetil. 2025; 166(27):\n 1060\u20131069.\n <\/jats:p>","DOI":"10.1556\/650.2025.33312","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T07:01:51Z","timestamp":1753081311000},"page":"1060-1069","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Polycyst\u00e1s ovarium szindr\u00f3m\u00e1s betegek \u00e9letmin\u0151s\u00e9g\u00e9t vizsg\u00e1l\u00f3 k\u00e9rd\u0151\u00edv magyar nyelv\u0171 adapt\u00e1ci\u00f3ja"],"prefix":"10.1556","volume":"166","author":[{"given":"Vivien","family":"Nagy","sequence":"first","affiliation":[{"name":"E\u00f6tv\u00f6s Lor\u00e1nd Tudom\u00e1nyegyetem, Szem\u00e9lyis\u00e9g- \u00e9s Eg\u00e9szs\u00e9gpszichol\u00f3gia Tansz\u00e9k Budapest, Izabella u. 46., 1064 Magyarorsz\u00e1g"},{"name":"E\u00f6tv\u00f6s Lor\u00e1nd Tudom\u00e1nyegyetem, Pszichol\u00f3giai Doktori Iskola Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Papp-Zipernovszky","sequence":"additional","affiliation":[{"name":"E\u00f6tv\u00f6s Lor\u00e1nd Tudom\u00e1nyegyetem, Szem\u00e9lyis\u00e9g- \u00e9s Eg\u00e9szs\u00e9gpszichol\u00f3gia Tansz\u00e9k Budapest, Izabella u. 46., 1064 Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of\n polycystic ovary syndrome. Clin Epidemiol. 2013; 6: 1\u201313.","DOI":"10.2147\/CLEP.S37559"},{"key":"R2","unstructured":"Speer G. Pathogenesis and epidemiology of PCOS In: Speer G, Lakatos\n P. (ed.) Polycystic Ovary Syndrome. [A PCOS patogenezise \u00e9s epidemiol\u00f3gi\u00e1ja. In:\n Speer G, Lakatos P. (szerk.) Policiszt\u00e1s ov\u00e1rium szindr\u00f3ma.] Semmelweis Kiad\u00f3,\n Budapest, 2009; pp. 25\u201346. [Hungarian]"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Kosova G, Urbanek M. Genetics of the polycystic ovary syndrome. Mol\n Cell Endocrinol. 2013; 373: 29\u201338.","DOI":"10.1016\/j.mce.2012.10.009"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"G\u0151d\u00e9ny S, Csenteri OK. Evidence-based therapy of polycystic ovarian\n syndrome. [A polycyst\u00e1s ovarium szindr\u00f3ma t\u00fcneteinek bizony\u00edt\u00e9kokon alapul\u00f3\n ter\u00e1pi\u00e1ja.] Orv Hetil. 2015; 156: 1803\u20131815. [Hungarian]","DOI":"10.1556\/650.2015.30253"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Williams S, Sheffield D, Knibb RC. A snapshot of the lives of women\n with polycystic ovary syndrome: a photovoice investigation. J Health Psychol.\n 2016; 21: 1170\u20131182.","DOI":"10.1177\/1359105314547941"},{"key":"R6","unstructured":"Moh\u00e1csi B. A qualitative and quantitative study of factors that\n negatively influence the quality of life of patients with polycystic ovary\n syndrome. PhD-dissertation. [A policiszt\u00e1s ov\u00e1rium szindr\u00f3m\u00e1val \u00e9l\u0151k\n \u00e9letmin\u0151s\u00e9g\u00e9t negat\u00edv ir\u00e1nyba befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k kvantitat\u00edv \u00e9s kvalitat\u00edv\n vizsg\u00e1lata. Doktori \u00e9rtekez\u00e9s.] Dissertation. Debreceni Egyetem,\n B\u00f6lcs\u00e9szettudom\u00e1nyi Kar, 2016. [Hungarian] Available from:\n https:\/\/dea.lib.unideb.hu\/server\/api\/core\/bitstreams\/adcaef06-bf7f-4caf-b3f4-e751a1541dd6\/content\n [accessed: March 23, 2025]."},{"key":"R7","doi-asserted-by":"crossref","unstructured":"T\u00f3th E, Szentiv\u00e1nyi-Mak\u00f3 H, Teleki S\u00c1. Polycystic ovary syndrome\n (PCOS) and its psychological consequences. [A policiszt\u00e1s ov\u00e1rium szindr\u00f3ma\n (PCOS) pszichol\u00f3giai k\u00f6vetkezm\u00e9nyei.] Ment\u00e1lhig Pszichoszom. 2024; 25: 176\u2013188.\n [Hungarian]","DOI":"10.1556\/0406.2024.00056"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Davitadze M, Malhotra K, Khalil H, et al. Body image concerns in\n women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur\n J Endocrinol. 2023; 189: R1\u2013R9.","DOI":"10.1093\/ejendo\/lvad110"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Yin X, Ji Y, Chan CL, et al. The mental health of women with\n polycystic ovary syndrome: a systematic review and meta-analysis. Arch Womens\n Ment Health 2021; 24: 11\u201327.","DOI":"10.1007\/s00737-020-01043-x"},{"key":"R10","unstructured":"M\u00e1rki G, Szuj\u00f3 S, P\u00e1pay N. Predictors of quality of life in women\n diagnosed with polycystic ovary syndrome. [A policiszt\u00e1s ov\u00e1rium szindr\u00f3m\u00e1val\n diagnosztiz\u00e1lt n\u0151k \u00e9letmin\u0151s\u00e9g\u00e9nek bej\u00f3sl\u00f3i.] Alk Pszichol. 2014; 14: 103\u2013116.\n [Hungarian]"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Cronin L, Guyatt G, Griffith L, et al. Development of a\n health-related quality-of-life questionnaire (PCOSQ) for women with polycystic\n ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998; 83:\n 1976\u20131987.","DOI":"10.1210\/jc.83.6.1976"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Micskei O, Deli T, Jakab A, et al. Body image and quality of life in\n women with polycystic ovary syndrome. [A testk\u00e9p \u00e9s \u00e9letmin\u0151s\u00e9g vizsg\u00e1lata\n polycyst\u00e1s ovarium szindr\u00f3m\u00e1ban.] Orv Hetil. 2014; 155: 1071\u20131077.\n [Hungarian]","DOI":"10.1556\/OH.2014.29944"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Snyder BS. The lived experience of women diagnosed with polycystic\n ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2006; 35:\n 385\u2013392.","DOI":"10.1111\/j.1552-6909.2006.00047.x"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Williams S, Sheffield D, Knibb RC. The Polycystic Ovary Syndrome\n Quality of Life scale (PCOSQOL): development and preliminary validation. Health\n Psychol Open 2018; 5: 2055102918788195.","DOI":"10.1177\/2055102918788195"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Jiskoot G, Somers S, De Roo C, et al. Translation of the Modified\n Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary\n Syndrome Quality of Life tool (PCOSQOL) in Dutch and Flemish women with PCOS. J\n Clin Med. 2023; 12: 3927.","DOI":"10.3390\/jcm12123927"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Gudmundsson E. Guidelines for translating and adapting psychological\n instruments. Nordic Psychol. 2009; 61: 29\u201345.","DOI":"10.1027\/1901-2276.61.2.29"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"The WHOQOL Group. Development of the World Health Organization\n WHOQOL-BREF quality of life assessment. Psychol Med. 1998; 28:\n 551\u2013558.","DOI":"10.1017\/S0033291798006667"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Paulik E, Belec B, Moln\u00e1r R, et al. Applicability of the brief\n version of the World Health Organization\u2019s quality of life questionnaire in\n Hungary. [Az Eg\u00e9szs\u00e9g\u00fcgyi Vil\u00e1gszervezet r\u00f6vid\u00edtett \u00e9letmin\u0151s\u00e9g k\u00e9rd\u0151\u00edv\u00e9nek\n hazai alkalmazhat\u00f3s\u00e1g\u00e1r\u00f3l.] Orv Hetil. 2007; 148: 155\u2013160.\n [Hungarian]","DOI":"10.1556\/OH.2007.27854"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Lovibond SH, Lovibond PF. Depression Anxiety and Stress Scales.\n (DASS\u201321, DASS\u201342). American Psychological Association, Washington, DC,\n 1995.","DOI":"10.1037\/t01004-000"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Szab\u00f3 M. The short version of the Depression Anxiety Stress Scales\n (DASS-21): factor structure in a young adolescent sample. J Adolesc. 2010; 33:\n 1\u20138.","DOI":"10.1016\/j.adolescence.2009.05.014"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Littleton HL, Axsom D, Pury CLS. Development of the body image\n concern inventory. Behav Res Ther. 2005; 43: 229\u2013241.","DOI":"10.1016\/j.brat.2003.12.006"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Littleton H, Breitkopf CR. The body image concern inventory:\n validation in a multiethnic sample and initial development of a Spanish language\n version. Body Image 2008; 5: 381\u2013388.","DOI":"10.1016\/j.bodyim.2008.06.004"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Luca M, Giannini M, Gori A, et al. Measuring dysmorphic concern in\n Italy: psychometric properties of the Italian Body Image Concern Inventory\n (I-BICI). Body Image 2011; 8: 301\u2013305.","DOI":"10.1016\/j.bodyim.2011.04.007"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Benetti-Pinto CL, Ferreira SR, Antunes A, et al. The influence of\n body weight on sexual function and quality of life in women with polycystic\n ovary syndrome. Arch Gynecol Obstet. 2015; 291: 451\u2013455.","DOI":"10.1007\/s00404-014-3423-1"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Rzo\u0144ca E, Bie\u0144 A, Wdowiak A, et al. Determinants of quality of life\n and satisfaction with life in women with polycystic ovary syndrome. Int J\n Elviron Res Public Health 2018; 15: 376.","DOI":"10.3390\/ijerph15020376"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Pik\u00f3 B, Nagy BGy, Ob\u00e1l A. Medical students\u2019 perceived stress and\n mental well-being in light of body mass index and eating behavior. A cluster\n analysis. [Orvostanhallgat\u00f3k stresszterhelts\u00e9ge \u00e9s ment\u00e1lis j\u00f3ll\u00e9te a\n testt\u00f6megindex \u00e9s az \u00e9tkez\u00e9si magatart\u00e1s t\u00fckr\u00e9ben: Klaszterelemz\u00e9s.] Orv Hetil.\n 2024; 165: 1659\u20131668. [Hungarian]","DOI":"10.1556\/650.2024.33155"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Hargittay C, V\u00f6r\u00f6s K, E\u0151ry A, et al. The association between\n diabetes complications and symptoms of depression and anxiety. [A cukorbetegs\u00e9g\n sz\u00f6v\u0151dm\u00e9nyeinek \u00f6sszef\u00fcgg\u00e9se a depresszi\u00f3s \u00e9s szorong\u00e1sos t\u00fcnetekkel.] Orv\n Hetil. 2023; 164: 79\u201387. [Hungarian]","DOI":"10.1556\/650.2023.32676"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade\n inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021; 22:\n 3789.","DOI":"10.3390\/ijms22073789"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Glaus J, von K\u00e4nel R, Lasserre AM, et al. The bidirectional\n relationship between anxiety disorders and circulating levels of inflammatory\n markers: results from a large longitudinal population-based study. Depress\n Anxiety 2018; 35: 360\u2013371.","DOI":"10.1002\/da.22710"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Himmerich H, Fulda S, Linseisen J, et al. Depression, comorbidities\n and the TNF-\u03b1 system. Eur Psychiatry 2008; 23: 421\u2013429.","DOI":"10.1016\/j.eurpsy.2008.03.013"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Osimo EF, Baxter LJ, Lewis G, et al. Prevalence of low-grade\n inflammation in depression: a systematic review and meta-analysis of CRP levels.\n Psychol Med. 2019; 49: 1958\u20131970.","DOI":"10.1017\/S0033291719001454"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Al-Mansoori L, Al-Jaber H, Prince MS, et al. Role of inflammatory\n cytokines, growth factors and adipokines in adipogenesis and insulin resistance.\n Inflammation 2022; 45: 31\u201344.","DOI":"10.1007\/s10753-021-01559-z"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Agorastos A, Chrousos GP. The neuroendocrinology of stress: the\n stress-related continuum of chronic disease development. Mol Psychiatry 2022;\n 27: 502\u2013513.","DOI":"10.1038\/s41380-021-01224-9"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/27\/article-p1060.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/27\/article-p1060.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/27\/article-p1060.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:36:13Z","timestamp":1785422173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/27\/article-p1060.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":33,"journal-issue":{"issue":"27"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33312","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]}}}